RT
TMO icon

Rockland Trust’s Thermo Fisher Scientific TMO Stock Holding History

Rockland Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4M Buy
64,639
+2,546
+4% +$1.22M 1.27% 22
2026
Q1 		$30.5M Buy
62,093
+2,960
+5% +$1.61M 1.22% 22
2025
Q4 		$34.3M Sell
59,133
-4,859
-8% -$2.75M 1.35% 20
2025
Q3 		$31M Buy
63,992
+9,467
+17% +$4.41M 1.27% 22
2025
Q2 		$22.1M Buy
54,525
+21,739
+66% +$9.09M 1.08% 33
2025
Q1 		$16.3M Buy
32,786
+727
+2% +$394K 0.82% 39
2024
Q4 		$16.7M Buy
32,059
+1,721
+6% +$946K 0.85% 37
2024
Q3 		$18.8M Buy
30,338
+483
+2% +$286K 0.92% 37
2024
Q2 		$16.5M Buy
29,855
+1,114
+4% +$638K 0.87% 38
2024
Q1 		$16.7M Buy
28,741
+1,951
+7% +$1.09M 0.88% 39
2023
Q4 		$14.2M Buy
26,790
+123
+0.5% +$59.5K 0.78% 42
2023
Q3 		$13.5M Buy
26,667
+1,332
+5% +$710K 0.81% 40
2023
Q2 		$13.2M Sell
25,335
-27
-0.1% -$14.6K 0.79% 42
2023
Q1 		$14.6M Sell
25,362
-575
-2% -$324K 0.92% 33
2022
Q4 		$14.3M Buy
25,937
+55
+0.2% +$29.1K 0.91% 39
2022
Q3 		$13.1M Sell
25,882
-25
-0.1% -$14K 0.94% 41
2022
Q2 		$14.1M Buy
25,907
+357
+1% +$197K 0.97% 36
2022
Q1 		$15.1M Buy
25,550
+251
+1% +$144K 0.96% 37
2021
Q4 		$16.9M Sell
25,299
-968
-4% -$604K 1.08% 29
2021
Q3 		$15M Sell
26,267
-890
-3% -$488K 1.05% 32
2021
Q2 		$13.7M Sell
27,157
-552
-2% -$260K 0.95% 39
2021
Q1 		$12.6M Sell
27,709
-1,857
-6% -$886K 0.91% 37
2020
Q4 		$13.8M Sell
29,566
-1,582
-5% -$742K 1.07% 35
2020
Q3 		$13.8M Sell
31,148
-1,913
-6% -$790K 1.18% 27
2020
Q2 		$12M Sell
33,061
-1,495
-4% -$501K 1.08% 30
2020
Q1 		$9.8M Sell
34,556
-3,071
-8% -$968K 1% 39
2019
Q4 		$12.2M Sell
37,627
-13,881
-27% -$4.21M 1.01% 38
2019
Q3 		$14.6M Sell
51,508
-472
-0.9% -$135K 1.32% 24
2019
Q2 		$15.3M Sell
51,980
-2,591
-5% -$714K 1.51% 20
2019
Q1 		$14.9M Sell
54,571
-5,643
-9% -$1.4M 1.58% 18
2018
Q4 		$13.5M Sell
60,214
-1,816
-3% -$426K 1.65% 17
2018
Q3 		$15.1M Sell
62,030
-1,300
-2% -$299K 1.85% 13
2018
Q2 		$13.1M Buy
63,330
+755
+1% +$160K 1.69% 19
2018
Q1 		$12.9M Buy
62,575
+243
+0.4% +$51K 1.71% 17
2017
Q4 		$11.8M Buy
62,332
+4,221
+7% +$809K 1.52% 21
2017
Q3 		$11M Buy
58,111
+4,350
+8% +$788K 1.64% 22
2017
Q2 		$9.38M Buy
53,761
+26,682
+99% +$4.48M 1.47% 28
2017
Q1 		$4.16M Buy
27,079
+474
+2% +$72.4K 0.66% 47
2016
Q4 		$3.75M Buy
26,605
+245
+0.9% +$36.1K 0.6% 50
2016
Q3 		$4.19M Buy
26,360
+383
+1% +$59K 0.73% 45
2016
Q2 		$3.84M Buy
25,977
+195
+0.8% +$28.8K 0.66% 49
2016
Q1 		$3.65M Buy
25,782
+522
+2% +$70K 0.66% 48
2015
Q4 		$3.58M Buy
25,260
+1,046
+4% +$140K 0.63% 47
2015
Q3 		$2.96M Buy
24,214
+16,682
+221% +$2.17M 0.58% 45
2015
Q2 		$977K Buy
+7,532
New +$982K 0.19% 71

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Rockland Trust's TMO Position: Q2 2026 in Review

Rockland Trust increased its Thermo Fisher Scientific (TMO) stake by 4.1% in Q2 2026, buying an estimated $1.22M and bringing the position to 64,639 shares worth $32.4M. The position accounts for 1.27% of the portfolio, ranked #22.

Rockland Trust first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $34.3M in Q4 2025. 627 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Rockland Trust held 64,639 shares of Thermo Fisher Scientific worth $32.4M as of Q2 2026.
  • Rockland Trust bought 2,546 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.22M.
  • Thermo Fisher Scientific made up 1.27% of Rockland Trust's portfolio in Q2 2026, its #22 holding.
  • Rockland Trust first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
  • Rockland Trust's Thermo Fisher Scientific position peaked at $34.3M in Q4 2025.
  • 627 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.